Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Neoplasms × Psychiatric Rehabilitation × Clear all

Phase

Status

Completed 5 Unknown 1 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Stomach Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Liver Neoplasms 1 Kidney Neoplasms 1 Gallbladder Neoplasms 1 Esophageal Neoplasms 1 Depression 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1 Anxiety Disorders 1 Anus Neoplasms 1

Interventions

Gemcitabine 29 pembrolizumab 22 Cyclophosphamide 19 Paclitaxel 17 Irinotecan 17 Carboplatin 17 Fluorouracil 16 Docetaxel 16 Capecitabine 16 Leucovorin 13 Bevacizumab 12 fludarabine 11 Oxaliplatin 11 Everolimus 11 Pemetrexed 10 Erlotinib Hydrochloride 10 Dexamethasone 10 Rituximab 9 Cisplatin 9 Blood Specimen Collection 9 venetoclax 8 Cetuximab 8 Trastuzumab 7 Nivolumab 7 Sunitinib 6 Ipilimumab 6 Epoetin Alfa 6 Bortezomib 6 Azacitidine 6 trametinib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02440737 2019-10-18

NEST

Vanderbilt-Ingram Cancer Center

Phase NA Terminated

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡